BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.130
-0.010 (-0.88%)
May 22, 2026, 4:00 PM EDT - Market closed
BioXcel Therapeutics Employees
BioXcel Therapeutics had 29 employees as of December 31, 2025. The number of employees decreased by 8 or -21.62% compared to the previous year.
Employees
29
Change (1Y)
-8
Growth (1Y)
-21.62%
Revenue / Employee
$23,448
Profits / Employee
-$2,597,724
Market Cap
34.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | -8 | -21.62% |
| Dec 31, 2024 | 37 | -37 | -50.00% |
| Dec 31, 2023 | 74 | -109 | -59.56% |
| Dec 31, 2022 | 183 | 94 | 105.62% |
| Dec 31, 2021 | 89 | 39 | 78.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 269 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Aytu BioPharma | 83 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
| Talphera | 12 |
BTAI News
- 10 days ago - BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c) - TheFly
- 10 days ago - BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 10 days ago - BioXcel Therapeutics Quarterly report: Q1 2026 - Filings
- 10 days ago - BioXcel Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - BioXcel Therapeutics Transcript: Investor update - Transcripts
- 4 weeks ago - BioXcel Therapeutics Slides: Investor update - Filings
- 5 weeks ago - BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting - GlobeNewsWire
- 6 weeks ago - Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire